Nurix Therapeutics (NRIX) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 4 Phase 1[2].
NRIX has 1 Form 4 insider filing recorded at the SEC in the past 30 days[4].
NRIX is tracked by BiotechSigns with a current catalyst score of 39/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-04.
Nurix Therapeutics (NRIX) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 4 Phase 1[2].
NRIX has 1 Form 4 insider filing recorded at the SEC in the past 30 days[4].